Maxim Group Downgrades Immune Pharmaceuticals (IMNP) to Hold CIting Financing Concerns
Tweet Send to a Friend
Maxim Group downgraded Immune Pharmaceuticals (NASDAQ: IMNP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
